Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC70
TNBC
Basal A
Bosutinib
Src
nRTK
12400.17
uM
0.95624
1.36560
-0.7750 -0.7429 2.5554 0.4530
0.9957
1.1992
HCC70
TNBC
Basal A
Bosutinib
Src
nRTK
10873.145
uM
0.9820
2.45510
-0.8901 -0.8689 1.0991 0.5283
0.9970
1.2454
HCC70
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
7857.011
uM
12.96930
16.26290
-0.9756 -0.9722 4.7718 0.6272
0.9991
1.0477
HCC70
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
7860.011
uM
17.88260
22.44810
-0.9954 -0.9945 4.8154 0.6186
0.9991
0.7135
HCC70
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
9501.011
uM
13.60390
16.92010
-0.9869 -0.9881 4.9994 0.6318
0.9993
0.9301
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
7856.018
uM
inf
inf
0.8811 0.8811 0.0000 0.0121
0.4683
0.9388
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
7857.042
uM
inf
0.00139
0.7456 0.7944 5.0000 0.1040
0.8457
1.1910
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
7860.042
uM
1.41750
6.04060
0.6742 -0.9996 0.7577 0.0164
0.8799
0.6736
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
9501.026
uM
inf
0.01283
0.4925 0.5840 1.2619 0.0978
0.8957
0.7616
HCC70
TNBC
Basal A
CGC-11047
Polyamine analogue
7856.018
uM
3.24150
49.7860
-0.9805 -1.0000 0.4022 0.7437
0.8488
0.9388
HCC70
TNBC
Basal A
CGC-11047
Polyamine analogue
9501.026
uM
0.63315
10.41250
-0.9773 -1.0000 0.3924 0.9469
0.8501
0.7616
HCC70
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
9501.03
uM
inf
inf
-0.9987 -0.9987 0.0000 0.4685
0.5497
0.6902
HCC70
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7860.017
uM
2.40830
3.01010
-0.9990 -0.9990 4.9226 0.6684
0.9951
0.6196
HCC70
TNBC
Basal A
Cisplatin
DNA cross-linker
DNA cross-linker
7857.017
uM
1.60450
2.36240
-0.9732 -0.9789 2.8032 0.7284
0.9991
1.1840
HCC70
TNBC
Basal A
CPT-11
TOP1
TOP
7860.043
uM
inf
inf
0.9822 0.9822 0.0000 0.0201
0.2254
0.7488
HCC70
TNBC
Basal A
CPT-11
TOP1
TOP
9501.121
uM
12.38040
17.6920
-0.9538 -0.9706 3.0220 0.2061
0.9962
0.7121
HCC70
TNBC
Basal A
Dactolisib
PI3K
PI3K
10873.155
uM
0.11517
0.08168
0.1060 0.1377 0.9376 0.4610
0.7766
1.2787
HCC70
TNBC
Basal A
Dactolisib
PI3K
PI3K
12400.155
uM
0.13114
0.13888
-0.0575 -0.0800 2.5868 0.4826
0.9924
1.2558
HCC70
TNBC
Basal A
Dichloroacetate
PDK
PDK
12714.176
uM
0.59743
168.50620
0.2521 -1.0000 0.1947 0.2769
0.5769
0.3108
HCC70
TNBC
Basal A
Disulfiram
Proteasome
Proteasome
12714.174
uM
inf
inf
1.0210 1.0210 0.0000 0.2086
0.0000
0.3306
HCC70
TNBC
Basal A
Docetaxel
TUBB
TUBB
9501.002
uM
0.00302
0.00582
-0.5255 -0.5680 1.1563 0.9048
0.9833
1.0082
HCC70
TNBC
Basal A
Docetaxel
TUBB
TUBB
12714.002
uM
0.00244
0.00428
-0.7131 -0.7666 1.6607 1.0519
0.9839
0.4328
HCC70
TNBC
Basal A
Docetaxel
TUBB
TUBB
7857.002
uM
0.00680
0.00914
-0.2632 -0.3133 1.6486 0.7292
0.9850
1.1921
HCC70
TNBC
Basal A
Doxorubicin
TOP2
TOP
7860.043
uM
3.99210
5.72270
-0.9934 -0.9983 3.0475 0.4398
0.9815
0.7488
HCC70
TNBC
Basal A
Doxorubicin
TOP2
TOP
9501.121
uM
0.26936
0.55094
-0.9997 -1.0000 1.5353 0.7865
0.9962
0.7121